Brooke LeVasseur | Source | CEO at AristaMD

The thing that really keeps me up at night every night, is that without a lasting sustainable economic model, these innovations will not be able to continue. As an industry, we need to really be focused on working to get reimbursement models in place that reflect the value that these new innovations can deliver so that ultimately providers will have their incentives aligned to continue to adopt and use these tools that do have demonstrated efficacy and that have demonstrated value.